Differential exoprotease activities confer tumor-specific serum peptidome patterns - Wikidata - awgldk - TriplyDB

Differential exoprotease activities confer tumor-specific serum peptidome patterns

Differential exoprotease activities confer tumor-specific serum peptidome patterns

http://www.wikidata.org/entity/Q33230965

about

Comparison of tear protein levels in breast cancer patients and healthy controls using a de novo proteomic approach Cancer biomarkers The impact of biosampling procedures on molecular data interpretation Proteomics of ovarian cancer: functional insights and clinical applications Serum peptidome variations in a healthy population: reference to identify cancer-specific peptides Blood peptidome-degradome profile of breast cancer Serum apolipoproteins C-I and C-III are reduced in stomach cancer patients: results from MALDI-based peptidome and immuno-based clinical assays Elevated levels of the complement activation product C4d in bronchial fluids for the diagnosis of lung cancer.Fundamentals and application of magnetic particles in cell isolation and enrichment: a review New tools and new biology: recent miniaturized systems for molecular and cellular biology.CE-MS analysis of the human urinary proteome for biomarker discovery and disease diagnostics.Label-free cell separation and sorting in microfluidic systems Thrombin induces broad spectrum proteolysis in human serum samples.Mass spectrometry-based analysis of therapy-related changes in serum proteome patterns of patients with early-stage breast cancer.Identification of disease- and therapy-associated proteome changes in the sera of patients with myelodysplastic syndromes and del(5q).Early diagnostic protein biomarkers for breast cancer: how far have we come?A panel of kallikrein markers can reduce unnecessary biopsy for prostate cancer: data from the European Randomized Study of Prostate Cancer Screening in Göteborg, Sweden.Sparse Proteomics Analysis - a compressed sensing-based approach for feature selection and classification of high-dimensional proteomics mass spectrometry data Clinical proteomics and mass spectrometry profiling for cancer detection.MALDI-TOF serum protein profiling for the detection of breast cancer.Human body fluid proteome analysis.Peak selection from MALDI-TOF mass spectra using ant colony optimization.Candidate markers for the detection of hepatocellular carcinoma in low-molecular weight fraction of serum.Diagnostic accuracy of MALDI mass spectrometric analysis of unfractionated serum in lung cancer.Proteomic approach to breast cancer.A sequence-specific exopeptidase activity test (SSEAT) for "functional" biomarker discovery.Enrichment and detection of molecules secreted by tumor cells using magnetic reversed-phase particles and LC-MALDI-TOF-MS.Serum biomarker profile associated with high bone turnover and BMD in postmenopausal women.Liquid chromatography/tandem mass spectrometric method for the quantification of eight proteolytic fragments of ITIH4 with biomarker potential in human plasma and serum.Validation of previously identified serum biomarkers for breast cancer with SELDI-TOF MS: a case control study Adapting mass spectrometry-based platforms for clinical proteomics applications: The capillary electrophoresis coupled mass spectrometry paradigm.Influence of sample storage duration on serum protein profiles assessed by surface-enhanced laser desorption/ionisation time-of-flight mass spectrometry (SELDI-TOF MS).Approaching clinical proteomics: current state and future fields of application in fluid proteomics.Identification of macrophage migration inhibitory factor and human neutrophil peptides 1-3 as potential biomarkers for gastric cancer Mass spectrometry-based serum proteome pattern analysis in molecular diagnostics of early stage breast cancer.Monitoring peptidase activities in complex proteomes by MALDI-TOF mass spectrometry Prediction of outcome of non-small cell lung cancer patients treated with chemotherapy and bortezomib by time-course MALDI-TOF-MS serum peptide profiling.Mesoporous silica chips for selective enrichment and stabilization of low molecular weight proteome.HDL in humans with cardiovascular disease exhibits a proteomic signature.A four-kallikrein panel predicts prostate cancer in men with recent screening: data from the European Randomized Study of Screening for Prostate Cancer, Rotterdam.

P2860

Q24337286-5BD31196-39E9-4715-BE5D-6039EF37217C Q26864429-197786AC-27DC-40F7-AD22-AF14E42F90F2 Q26991764-8BEEAE72-B51F-42E4-8F33-AECD719ED722 Q28082632-D411524D-CF3E-452A-BA97-D4B05C6B1473 Q28397855-A4ABDA23-EE39-4662-95B9-DFD6FA73BCA1 Q28475815-C2024955-A6E0-49D1-B5C1-D193AD399E35 Q28743469-F3538494-2B82-4F97-AF7A-D6B029B763C5 Q30316699-3A1BC278-5C64-430C-9A54-7885184951D5 Q30395055-DE529FAB-FF7A-444E-981C-39025D79DA70 Q30422227-911574FC-BB1C-4375-B71E-BFD08FA75F96 Q30437141-92E4DF7D-CFA5-41DC-80F1-E8C32CBE5728 Q30480042-B00A37BC-0BE4-4D2F-BB03-3D560BB68F5F Q30855514-1B9BFE0C-E957-48BD-AFFE-57AB52930EF8 Q30985472-0BA5A3F8-1614-4B4A-AA9E-5EA0FF628F8A Q30987570-25AA7859-D015-4AAB-882F-BD4479834D4A Q31043570-3359DAE5-ADC2-4694-810C-9F39FFC3B20C Q31161981-6750072A-D0C4-4916-82B4-58737C7F71AB Q31172638-DBF06F2D-4146-4ADA-8BA2-D855804FF0CB Q33246668-021076C1-240A-474B-A689-7F82D91AAEC0 Q33261717-66FC0980-154A-4103-9BF4-B8707AF13DDA Q33262623-A7F3BC5B-3E64-4A9F-B083-6A7B267E8485 Q33269730-FADBEC32-F6E8-44D5-810C-562807EEEFBD Q33295308-4DE79C51-F28D-4959-88B0-5B57DC1979E2 Q33301109-4DD2B076-BB0F-44DA-8ED0-515DD8FB23EB Q33301436-FED9E599-9190-4094-B37A-FF15CF1A1667 Q33305170-120D4391-181E-4F42-BD9E-D22B7B17BB69 Q33312897-4C3DBCE9-3023-4AB3-A2B0-359659FF0B65 Q33321301-025C4241-5424-40C8-A0C4-67BD7BBF467B Q33364206-ABF9E2CF-FCF8-4053-81C3-D28F3D97CB8E Q33400847-29D2EB61-D0DE-4AE3-B6D3-F62A3D29587A Q33436829-95E4C37F-6BDA-4919-BDD0-844D8C04B106 Q33439145-F9597BB8-9A4B-46BB-8ADF-7CF8447428AB Q33467523-04317023-DB52-42C0-9BA3-244062C88557 Q33473141-B7CAFC19-994F-4256-915A-D27BA5509D96 Q33481276-B3925EBC-F320-4314-9724-E9201D2A7861 Q33484162-835FD325-6DE4-4B1F-AC40-0D6668A2EB42 Q33499899-63796CC3-4200-4B2D-9D3C-0E5D9E21E14F Q33518743-FBD8164E-3B66-4BA2-BD96-1443BAB4E144 Q33544033-55195A14-6176-45DC-A176-06A1EA11E782 Q33558289-33F51247-CDE2-4C2B-A227-5F8B2A0222EA

P2860

Differential exoprotease activities confer tumor-specific serum peptidome patterns

http://www.wikidata.org/entity/Q33230965

description

2006 nî lūn-bûn

@nan

2006 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Differential exoprotease activities confer tumor-specific serum peptidome patterns

@ast

Differential exoprotease activities confer tumor-specific serum peptidome patterns

@en

type

label

Differential exoprotease activities confer tumor-specific serum peptidome patterns

@ast

Differential exoprotease activities confer tumor-specific serum peptidome patterns

@en

prefLabel

Differential exoprotease activities confer tumor-specific serum peptidome patterns

@ast

Differential exoprotease activities confer tumor-specific serum peptidome patterns

@en

P1433

Q33230965-3A7857E6-6D1A-4F92-BE37-5AEA107A4A74

P1476

Q33230965-B3CA6798-3A3E-4C5F-B478-0B076CA6E7A8

P2093

Q33230965-090172FB-1614-4D76-97B3-6EFD10280992

Q33230965-0F8AE853-D6F4-4529-B053-6BFF732903EA

Q33230965-17A82F79-C363-478F-83D3-CCEC1C1F635F

Q33230965-46742AE9-3F2F-4AEF-B47C-3232D14F4EF3

Q33230965-AAFD4A71-BA24-42D9-888C-87B7FCE7B567

Q33230965-B08A5584-F863-4D2C-BE1A-65EE2F0C77BA

Q33230965-B1F6D660-6245-4790-BED8-7ABC5EA8A2E7

Q33230965-C0057B97-FB03-463A-98E5-6063584BA835

Q33230965-C240502F-DBFD-46B2-82C4-64BFA59DDBCB

Q33230965-D3F9EABC-5F34-40D6-84A3-FABA0D9FAE69

P2860

Q33230965-03358AEA-5FE5-4B1F-8D54-17404B02B08F

Q33230965-0D419C18-ACD3-4BFA-B7A0-A074DE5013B4

Q33230965-0F213F3A-75A5-46A4-BA96-EBDDA0F56943

Q33230965-10323CD9-36BE-4A32-804E-92AFE3A59314

Q33230965-16EB4D9B-F4F8-4868-B2F1-2E4B6680A4AB

Q33230965-1D34DC14-B241-4100-ACDD-93DE24691F8A

Q33230965-1D9E1CB1-4995-4AC9-B34E-F5B703A189AD

Q33230965-1DA7D99A-7BAB-4ABF-A05E-1959F18E9534

Q33230965-22524308-107A-41FE-B977-F897421ADCB7

Q33230965-2617F34C-0265-442D-9251-03688D1021AA

P304

Q33230965-65BF47ED-F7BA-46C9-9E9A-F84495F18202

P31

Q33230965-03FE7BB5-7604-4375-BF1F-CE0DBE142454

P356

Q33230965-2AC4A0E0-4FEE-445A-9997-919EF96DD389

P407

Q33230965-B4F92CA2-420E-4D9C-AA49-1ED32090C328

P433

Q33230965-55FFBB69-9FD4-4B32-8E72-F86EE4C19519

P478

Q33230965-2D5BFA7F-64B5-4506-BC35-D216089E8D90

P50

Q33230965-037C998D-1271-4F7A-AB7B-770A254737EF

Q33230965-298EB455-D487-4997-8097-EB063BAF7D8E

Q33230965-3D62D74C-FFDB-4A07-BFB4-98DE78863451

Q33230965-9A97FA44-75A2-4C72-8D93-8E4535B09576

P577

Q33230965-324C79DE-AACE-449D-AEA4-A9FBFF6A3C1A

P698

Q33230965-B97E7E2C-609E-4208-A54C-126C28C73249

P932

Q33230965-B050E695-354D-4CB7-BED3-18F4DC534F77

P356

P1433

Journal of Clinical Investigation

P1476

Differential exoprotease activities confer tumor-specific serum peptidome patterns

@en

P2093

Adam B Olshen

http://www.w3.org/2001/XMLSchema#string

Carlos A Chaparro

http://www.w3.org/2001/XMLSchema#string

David R Shaffer

http://www.w3.org/2001/XMLSchema#string

Edi Brogi

http://www.w3.org/2001/XMLSchema#string

Eric C Holland

http://www.w3.org/2001/XMLSchema#string

Howard I Scher

http://www.w3.org/2001/XMLSchema#string

Jeff Boyd

http://www.w3.org/2001/XMLSchema#string

John Philip

http://www.w3.org/2001/XMLSchema#string

Josep Villanueva

http://www.w3.org/2001/XMLSchema#string

Marta Sanchez-Carbayo

http://www.w3.org/2001/XMLSchema#string

P2860

Initial sequencing and analysis of the human genome

High expression of methionine aminopeptidase 2 in human colorectal adenocarcinomas

Characterization of a novel, cytokine-inducible carboxypeptidase D isoform in haematopoietic tumour cells

Molecular recognition of angiogenesis inhibitors fumagillin and ovalicin by methionine aminopeptidase 2

Composition of the peptide fraction in human blood plasma: database of circulating human peptides

Structure and biology of complement protein C3, a connecting link between innate and acquired immunity

Toward a human blood serum proteome: analysis by multidimensional separation coupled with mass spectrometry

Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer

The human plasma proteome: history, character, and diagnostic prospects

Isolation and identification of hydroxyproline analogues of bradykinin in human urine

P304

271-284

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI26022

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

116

http://www.w3.org/2001/XMLSchema#string

P50

Carlos Cordon-Cardo

Hediye Erdjument-Bromage

P577

2006-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16395409

http://www.w3.org/2001/XMLSchema#string

P932

1323259

http://www.w3.org/2001/XMLSchema#string